Bicycle Therapeutics Ownership 2024 | Who Owns Bicycle Therapeutics Now?


OverviewForecastRevenueFinancialsChart

Institutional Ownership

12.99%

Insider Ownership

0.97%

Retail Ownership

86.03%

Institutional Holders

48.00

Bicycle Therapeutics Institutional Shareholders


Institutional Shareholders by % of Total Shares

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
BAKER BROS. ADVISORS LP11.65%1.54%4,942,8233,152,433176.08%123,076,293Mar 31, 2024
DEEP TRACK CAPITAL, LP8.23%2.49%3,490,506--86,913,599Mar 31, 2024
PARADIGM BIOCAPITAL ADVISORS LP7.65%2.85%3,246,759-460,242-12.42%80,844,299Mar 31, 2024
ARMISTICE CAPITAL, LLC3.94%0.55%1,672,000136,0008.85%41,632,800Mar 31, 2024
TYBOURNE CAPITAL MANAGEMENT (HK) LTD3.64%6.58%1,545,026-105,294-6.38%38,471,148Mar 31, 2024
MORGAN STANLEY3.58%0.00%1,516,715487,49047.36%37,766,203Mar 31, 2024
FIRST LIGHT ASSET MANAGEMENT, LLC2.81%2.27%1,193,051-357,420-23.05%29,706,970Mar 31, 2024
WESTFIELD CAPITAL MANAGEMENT CO LP2.45%0.14%1,038,917121,61313.26%25,869,033Mar 31, 2024
POLAR CAPITAL HOLDINGS PLC2.37%0.13%1,004,535--25,012,922Mar 31, 2024
SUVRETTA CAPITAL MANAGEMENT, LLC2.16%0.85%914,476--22,770,452Mar 31, 2024
CANDRIAM S.C.A.2.10%0.14%889,25820,0002.30%22,142,524Mar 31, 2024
BNP PARIBAS ASSET MANAGEMENT HOLDING S.A.2.08%0.06%883,105100,10712.79%21,989,000Mar 31, 2024
RA CAPITAL MANAGEMENT, L.P.1.89%0.03%800,000--19,920,000Mar 31, 2024
BLACKROCK INC.1.36%0.00%575,03073,40714.63%14,318,247Mar 31, 2024
AXA S.A.1.31%0.04%554,163770.01%13,798,659Mar 31, 2024
PARKMAN HEALTHCARE PARTNERS LLC1.24%1.60%524,253211,36467.55%13,053,900Mar 31, 2024
CAMBER CAPITAL MANAGEMENT LP1.06%0.27%450,000--11,205,000Mar 31, 2024
SCHONFELD STRATEGIC ADVISORS LLC0.99%0.07%420,800313,800293.27%10,477,920Mar 31, 2024
PRICE T ROWE ASSOCIATES INC /MD/0.95%0.00%401,646124,80945.08%10,001,000Mar 31, 2024
BANK OF AMERICA CORP /DE/0.94%0.00%396,812-64,519-13.99%9,880,620,000Mar 31, 2024

Bicycle Therapeutics's largest institutional shareholder is BAKER BROS. ADVISORS LP, holding 11.65% of the company's total share outstanding, currently valued at $123.08M. The top 10 institutional shareholders own together 48.48% of the company.

Institutional Shareholders by % of Total Assets

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
TYBOURNE CAPITAL MANAGEMENT (HK) LTD3.64%6.58%1,545,026-105,294-6.38%38,471,148Mar 31, 2024
PARADIGM BIOCAPITAL ADVISORS LP7.65%2.85%3,246,759-460,242-12.42%80,844,299Mar 31, 2024
DEEP TRACK CAPITAL, LP8.23%2.49%3,490,506--86,913,599Mar 31, 2024
FIRST LIGHT ASSET MANAGEMENT, LLC2.81%2.27%1,193,051-357,420-23.05%29,706,970Mar 31, 2024
PARKMAN HEALTHCARE PARTNERS LLC1.24%1.60%524,253211,36467.55%13,053,900Mar 31, 2024
BAKER BROS. ADVISORS LP11.65%1.54%4,942,8233,152,433176.08%123,076,293Mar 31, 2024
HIGHVISTA STRATEGIES LLC0.37%1.41%158,293--3,941,496Mar 31, 2024
ALPHACENTRIC ADVISORS LLC0.14%0.90%60,00060,000100.00%1,494,000Mar 31, 2024
SUVRETTA CAPITAL MANAGEMENT, LLC2.16%0.85%914,476--22,770,452Mar 31, 2024
DAFNA CAPITAL MANAGEMENT LLC0.29%0.69%122,200--3,042,780Mar 31, 2024
ARMISTICE CAPITAL, LLC3.94%0.55%1,672,000136,0008.85%41,632,800Mar 31, 2024
PLATINUM INVESTMENT MANAGEMENT LTD0.79%0.33%333,001-29,079-8.03%8,291,725Mar 31, 2024
SOLEUS CAPITAL MANAGEMENT, L.P.0.36%0.28%153,00058,00061.05%3,809,700Mar 31, 2024
CAMBER CAPITAL MANAGEMENT LP1.06%0.27%450,000--11,205,000Mar 31, 2024
WEXFORD CAPITAL LP0.08%0.18%34,879--868,487Mar 31, 2024
UBS OCONNOR LLC0.20%0.15%84,98011,37915.46%2,116,002Mar 31, 2024
RUBRIC CAPITAL MANAGEMENT LP0.48%0.15%205,423--5,115,033Mar 31, 2024
CANDRIAM S.C.A.2.10%0.14%889,25820,0002.30%22,142,524Mar 31, 2024
HARBOR CAPITAL ADVISORS, INC.0.10%0.14%43,48016,79262.92%1,083,000Mar 31, 2024
L & S ADVISORS INC0.12%0.14%50,26040,070393.23%1,251,474Mar 31, 2024

The largest Bicycle Therapeutics shareholder by % of total assets is TYBOURNE CAPITAL MANAGEMENT (HK) LTD. The company owns 1.55M shares of Bicycle Therapeutics (BCYC), representing 6.58% of its total assets.

Institutional Buyers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
BAKER BROS. ADVISORS LP11.65%1.54%4,942,8233,152,433176.08%123,076,293Mar 31, 2024
MORGAN STANLEY3.58%0.00%1,516,715487,49047.36%37,766,203Mar 31, 2024
SCHONFELD STRATEGIC ADVISORS LLC0.99%0.07%420,800313,800293.27%10,477,920Mar 31, 2024
PARKMAN HEALTHCARE PARTNERS LLC1.24%1.60%524,253211,36467.55%13,053,900Mar 31, 2024
DUQUESNE FAMILY OFFICE LLC0.45%0.11%190,200190,200100.00%4,736,000Mar 31, 2024
ARMISTICE CAPITAL, LLC3.94%0.55%1,672,000136,0008.85%41,632,800Mar 31, 2024
PRICE T ROWE ASSOCIATES INC /MD/0.95%0.00%401,646124,80945.08%10,001,000Mar 31, 2024
WESTFIELD CAPITAL MANAGEMENT CO LP2.45%0.14%1,038,917121,61313.26%25,869,033Mar 31, 2024
POINT72 ASSET MANAGEMENT, L.P.0.81%0.02%342,594116,69951.66%8,530,591Mar 31, 2024
BNP PARIBAS ASSET MANAGEMENT HOLDING S.A.2.08%0.06%883,105100,10712.79%21,989,000Mar 31, 2024
PINNACLE ASSOCIATES LTD0.19%0.03%80,09080,090100.00%1,994,241Mar 31, 2024
BLACKROCK INC.1.36%0.00%575,03073,40714.63%14,318,247Mar 31, 2024
RENAISSANCE TECHNOLOGIES LLC0.39%0.01%165,70060,20057.06%4,126,000Mar 31, 2024
ALPHACENTRIC ADVISORS LLC0.14%0.90%60,00060,000100.00%1,494,000Mar 31, 2024
SOLEUS CAPITAL MANAGEMENT, L.P.0.36%0.28%153,00058,00061.05%3,809,700Mar 31, 2024
GOLDMAN SACHS GROUP INC0.13%0.00%55,45055,450100.00%1,380,705Mar 31, 2024
NATIONAL BANK OF CANADA /FI/0.11%0.00%48,70048,700100.00%1,114,743Mar 31, 2024
SKANDINAVISKA ENSKILDA BANKEN AB (PUBL)0.10%0.01%42,72942,729100.00%1,063,525Mar 31, 2024
L & S ADVISORS INC0.12%0.14%50,26040,070393.23%1,251,474Mar 31, 2024
HANDELSBANKEN FONDER AB0.42%0.02%179,80040,00028.61%4,477,000Mar 31, 2024

As of Mar 31 2024, Bicycle Therapeutics's largest institutional buyer is BAKER BROS. ADVISORS LP. The company purchased 3.15M stocks of BCYC, valued at $123.08M.

Institutional Sellers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
JEFFERIES FINANCIAL GROUP INC.----1,948,000-100.00%-Mar 31, 2024
PARADIGM BIOCAPITAL ADVISORS LP7.65%2.85%3,246,759-460,242-12.42%80,844,299Mar 31, 2024
NOMURA HOLDINGS INC----400,000-100.00%-Mar 31, 2024
VERITION FUND MANAGEMENT LLC0.80%0.06%340,866-399,673-53.97%8,487,563Mar 31, 2024
FIRST LIGHT ASSET MANAGEMENT, LLC2.81%2.27%1,193,051-357,420-23.05%29,706,970Mar 31, 2024
FMR LLC----266,347-100.00%-Mar 31, 2024
MILLENNIUM MANAGEMENT LLC----249,135-100.00%-Mar 31, 2024
CITADEL ADVISORS LLC0.14%0.00%59,440-235,025-79.81%1,480,056Mar 31, 2024
MAN GROUP PLC----174,074-100.00%-Mar 31, 2024
KENNEDY CAPITAL MANAGEMENT LLC0.59%0.13%252,172-164,313-39.45%6,279,083Mar 31, 2024
WALLEYE CAPITAL LLC----150,126-100.00%-Mar 31, 2024
TYBOURNE CAPITAL MANAGEMENT (HK) LTD3.64%6.58%1,545,026-105,294-6.38%38,471,148Mar 31, 2024
CUBIST SYSTEMATIC STRATEGIES, LLC0.02%0.00%9,420-104,481-91.73%234,558Mar 31, 2024
TREXQUANT INVESTMENT LP0.22%0.05%92,552-103,771-52.86%2,304,545Mar 31, 2024
JUMP FINANCIAL, LLC----77,332-100.00%-Mar 31, 2024
TWO SIGMA INVESTMENTS, LP0.07%0.00%28,585-75,043-72.42%711,766Mar 31, 2024
BANK OF AMERICA CORP /DE/0.94%0.00%396,812-64,519-13.99%9,880,620,000Mar 31, 2024
JANE STREET GROUP, LLC0.05%0.00%20,197-62,753-75.65%502,906Mar 31, 2024
ADAR1 CAPITAL MANAGEMENT, LLC0.03%0.08%14,430-60,395-80.72%359,307Mar 31, 2024
UBS OCONNOR LLC0.17%0.01%70,000-55,000-44.00%129,500Mar 31, 2024

As of Mar 31 2024, Bicycle Therapeutics's biggest institutional seller is JEFFERIES FINANCIAL GROUP INC.. The company sold -1.95M shares of BCYC, valued at -.

Institutional New positions

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
DUQUESNE FAMILY OFFICE LLC0.45%0.11%190,200190,200100.00%4,736,000Mar 31, 2024
PINNACLE ASSOCIATES LTD0.19%0.03%80,09080,090100.00%1,994,241Mar 31, 2024
GOLDMAN SACHS GROUP INC0.13%0.00%55,45055,450100.00%1,380,705Mar 31, 2024
NATIONAL BANK OF CANADA /FI/0.11%0.00%48,70048,700100.00%1,114,743Mar 31, 2024
SKANDINAVISKA ENSKILDA BANKEN AB (PUBL)0.10%0.01%42,72942,729100.00%1,063,525Mar 31, 2024
CONCURRENT INVESTMENT ADVISORS, LLC0.05%0.02%21,79921,799100.00%542,796Mar 31, 2024
GILDER GAGNON HOWE & CO LLC0.05%0.01%21,26821,268100.00%529,573Mar 31, 2024
SUSQUEHANNA INTERNATIONAL GROUP, LLP0.02%-9,1009,100100.00%226,590Mar 31, 2024
PDS PLANNING, INC0.02%0.02%8,4508,450100.00%210,405Mar 31, 2024
US BANCORP \DE\0.00%-300300100.00%7,470Mar 31, 2024
0.00%0.00%3939100.00%971Mar 31, 2024

Bicycle Therapeutics's largest new institutional shareholder by number of shares is DUQUESNE FAMILY OFFICE LLC, purchased 190.20K shares, valued at $4.74M, as of undefined.

Institutional Sold Out

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
JEFFERIES FINANCIAL GROUP INC.----1,948,000-100.00%-Mar 31, 2024
NOMURA HOLDINGS INC----400,000-100.00%-Mar 31, 2024
FMR LLC----266,347-100.00%-Mar 31, 2024
MILLENNIUM MANAGEMENT LLC----249,135-100.00%-Mar 31, 2024
MAN GROUP PLC----174,074-100.00%-Mar 31, 2024
WALLEYE CAPITAL LLC----150,126-100.00%-Mar 31, 2024
JUMP FINANCIAL, LLC----77,332-100.00%-Mar 31, 2024
ADAR1 CAPITAL MANAGEMENT, LLC----54,100-100.00%-Mar 31, 2024
HRT FINANCIAL LP----19,913-100.00%-Mar 31, 2024
ENTRYPOINT CAPITAL, LLC----18,495-100.00%-Mar 31, 2024
PEAK6 INVESTMENTS LLC----6,000-100.00%-Mar 31, 2024
AQUATIC CAPITAL MANAGEMENT LLC----4,500-100.00%-Mar 31, 2024
ARETE WEALTH ADVISORS, LLC----3,772-100.00%-Mar 31, 2024
CLEAR STREET MARKETS LLC----1,500-100.00%-Mar 31, 2024
QUANTBOT TECHNOLOGIES LP----400-100.00%-Mar 31, 2024
RONALD BLUE TRUST, INC.----138-100.00%-Mar 31, 2024
ADVISORY SERVICES NETWORK, LLC----115-100.00%-Mar 31, 2024
ARLINGTON TRUST CO LLC----53-100.00%-Mar 31, 2024

Bicycle Therapeutics's largest sold out institutional shareholder by shares sold is JEFFERIES FINANCIAL GROUP INC., sold -1.95M shares, valued at -, as of undefined.

Bicycle Therapeutics Mutual Fund Holders


Name% Total AssetsTotal SharesChange AmountChange %Date
BlackRock Health Sciences Trust II0.10%278,270219,670374.86%Dec 31, 2023
TEKLA LIFE SCIENCES INVESTORS0.08%44,338--Dec 31, 2023
T. Rowe Price Health Sciences Fund, Inc.0.04%201,468-257,548-56.11%Dec 31, 2023
Listed Funds Trust0.03%14,396--Feb 29, 2024
VICTORY VARIABLE INSURANCE FUNDS0.02%10,860--Dec 31, 2023
HARBOR FUNDS0.02%425,769405,9482048.07%Jan 31, 2024
DEUTSCHE DWS SECURITIES TRUST0.02%8,070--Feb 29, 2024
FIDELITY ADVISOR SERIES VII0.01%120,100--Jan 31, 2024
T. Rowe Price New Horizons Fund, Inc.0.01%150,971--Dec 31, 2023
T. Rowe Price Equity Series, Inc.0.01%9,604-11,900-55.34%Dec 31, 2023
FIDELITY SELECT PORTFOLIOS0.00%266,347--Feb 29, 2024
ETFis Series Trust I0.00%5,4711,76647.67%Jan 31, 2024
DRIEHAUS MUTUAL FUNDS0.00%28,782--Dec 29, 2023
Harbor ETF Trust0.00%11,2683,00036.28%Jan 31, 2024
FIDELITY SECURITIES FUND0.00%214,959--Jan 31, 2024
BNY Mellon Strategic Funds, Inc.0.00%5,125--Mar 31, 2024
AdvisorShares Trust0.00%5,344--Dec 29, 2023
ALPS ETF Trust0.00%18,751--Feb 29, 2024
Brinker Capital Destinations Trust0.00%41,308--Feb 29, 2024
BlackRock ETF Trust0.00%570394223.86%Jan 31, 2024
ETF Series Solutions0.00%7,9141,26719.06%Feb 29, 2024
SPDR INDEX SHARES FUNDS0.00%35,866--Dec 31, 2023
MORGAN STANLEY PATHWAY FUNDS0.00%19,12019,120-Feb 29, 2024
PENN SERIES FUNDS INC0.00%5,197--Dec 29, 2023
RBB FUND, INC.0.00%14,975--Feb 29, 2024
VICTORY PORTFOLIOS0.00%2,928--Dec 31, 2023
LOOMIS SAYLES FUNDS II0.00%368,341--Dec 31, 2023
Virtus Investment Trust0.00%3,185--Dec 29, 2023
FIDELITY CONCORD STREET TRUST0.00%19,5062,36213.78%Feb 29, 2024
FIRST TRUST EXCHANGE-TRADED FUND II0.00%447--Dec 31, 2023
FIDELITY CAPITAL TRUST0.00%486--Jan 31, 2024
Brighthouse Funds Trust II0.00%83,657--Dec 31, 2023
MUTUAL FUND SERIES TRUST0.00%90,00031,50053.85%Dec 31, 2023
Blackstone Alternative Investment Funds0.00%2,600-300-10.34%Dec 31, 2023
iSHARES TRUST0.00%202,695--Feb 29, 2024
Invesco Exchange-Traded Fund Trust II0.00%3,2281,24062.37%Feb 29, 2024
PROSHARES TRUST0.00%2,58389953.38%Feb 29, 2024
Goldman Sachs Trust II0.00%55,81044,300384.88%Jan 31, 2024
Bridge Builder Trust0.00%56,026--Dec 31, 2023
EQ ADVISORS TRUST0.00%7,9681,75128.16%Dec 31, 2023
ADVANCED SERIES TRUST0.00%20,740--Dec 29, 2023
JOHN HANCOCK VARIABLE INSURANCE TRUST0.00%10,444--Dec 31, 2023
TRUST FOR PROFESSIONAL MANAGERS0.00%1,041-3,356-76.32%Feb 29, 2024
MASSMUTUAL SELECT FUNDS0.00%831--Dec 31, 2023
John Hancock Funds II0.00%4,984-6,055-54.85%Feb 29, 2024

Bicycle Therapeutics's largest mutual fund holder by % of total assets is "BlackRock Health Sciences Trust II", owning 278.27K shares, compromising 0.10% of its total assets.

Bicycle Therapeutics Institutional Ownership Trends


Institutional Holdings Trend

DateHoldingsChange %
31 Mar, 2448-53.85%
31 Dec, 231042.97%
30 Sep, 2310117.44%
30 Jun, 2386-7.53%
31 Mar, 23935.68%
31 Dec, 228815.79%
30 Sep, 2276-5.00%
30 Jun, 2280-27.93%
31 Mar, 2211112.12%
31 Dec, 219939.44%
30 Sep, 217133.96%
30 Jun, 215335.90%
31 Mar, 213944.44%
31 Dec, 202750.00%
30 Sep, 201820.00%
30 Jun, 201515.38%
31 Mar, 201362.50%
31 Dec, 198-27.27%
30 Sep, 1911-21.43%
30 Jun, 1914-

As of 31 Mar 24, 48 institutions are holding Bicycle Therapeutics's shares, representing a decrease of -53.85% compared to the previous quarter.

Shares Outstanding Trend

DateShares OutstandingChange %
31 Mar, 245,511,844-82.41%
31 Dec, 2331,340,809-3.07%
30 Sep, 2332,334,28533.13%
30 Jun, 2324,288,5203.35%
31 Mar, 2323,500,248-0.17%
31 Dec, 2223,540,4581.84%
30 Sep, 2223,115,3351.85%
30 Jun, 2222,695,86712.45%
31 Mar, 2220,182,855-6.33%
31 Dec, 2121,547,78351.83%
30 Sep, 2114,192,09314.34%
30 Jun, 2112,412,6398.68%
31 Mar, 2111,420,90055.84%
31 Dec, 207,328,447-2.94%
30 Sep, 207,550,16320.08%
30 Jun, 206,287,8375.19%
31 Mar, 205,977,3541.28%
31 Dec, 195,901,993-8.44%
30 Sep, 196,446,149-2.85%
30 Jun, 196,635,216-

Bicycle Therapeutics (BCYC) has 5.51M shares outstanding as of 31 Mar 24, down -82.41% compared to the previous quarter.

Institutional Ownership Trend

DateOwnership %Change %
31 Mar, 2412.99%0.21%
31 Dec, 2379.19%0.69%
30 Sep, 23107.10%1.63%
30 Jun, 2380.96%1.32%
31 Mar, 2378.33%1.24%
31 Dec, 2279.37%1.31%
30 Sep, 2277.89%1.33%
30 Jun, 2276.55%1.65%
31 Mar, 2268.17%1.22%
31 Dec, 2174.84%2.33%
30 Sep, 2156.68%2.13%
30 Jun, 2151.61%1.93%
31 Mar, 2151.68%4.27%
31 Dec, 2034.80%2.30%
30 Sep, 2038.86%3.21%
30 Jun, 2034.78%3.15%
31 Mar, 2033.21%1.16%
31 Dec, 1953.43%1.57%
30 Sep, 1958.36%0.71%
30 Jun, 1990.92%-

As of 31 Mar 24, Bicycle Therapeutics is held by 12.99% institutional shareholders, representing a 0.21% growth compared to 31 Dec 23.

Institutional Increased Positions Trend

DateIncreased PositionsChange %
31 Mar, 2428-50.00%
31 Dec, 2356-3.45%
30 Sep, 235852.63%
30 Jun, 2338-24.00%
31 Mar, 235047.06%
31 Dec, 223413.33%
30 Sep, 2230-37.50%
30 Jun, 2248-5.88%
31 Mar, 2251-23.88%
31 Dec, 216791.43%
30 Sep, 21356.06%
30 Jun, 213326.92%
31 Mar, 212662.50%
31 Dec, 2016128.57%
30 Sep, 207-
30 Jun, 207-
31 Mar, 207600.00%
31 Dec, 191-66.67%
30 Sep, 193-78.57%
30 Jun, 1914-

28 institutional shareholders have increased their position in BCYC stock as of 31 Mar 24 compared to 56 in the previous quarter (a -50.00% decrease).

Institutional Reduced Positions Trend

DateReduced PositionsChange %
31 Mar, 2412-61.29%
31 Dec, 233134.78%
30 Sep, 2323-17.86%
30 Jun, 232855.56%
31 Mar, 2318-47.06%
31 Dec, 223417.24%
30 Sep, 222981.25%
30 Jun, 2216-62.79%
31 Mar, 224372.00%
31 Dec, 21254.17%
30 Sep, 212484.62%
30 Jun, 211385.71%
31 Mar, 21740.00%
31 Dec, 205-28.57%
30 Sep, 207250.00%
30 Jun, 202-33.33%
31 Mar, 203-25.00%
31 Dec, 194-
30 Sep, 194-
30 Jun, 19--

12 institutional shareholders have reduced their position in BCYC stock as of 31 Mar 24 compared to 31 in the previous quarter (a -61.29% decrease).

All Institutional Ownership Trend Data

DateHoldingsChange %Shares OutstandingChange %Ownership %Change %Increased PositionsChange %Reduced PositionsChange %
31 Mar, 2448-53.85%5,511,844-82.41%12.99%0.21%28-50.00%12-61.29%
31 Dec, 231042.97%31,340,809-3.07%79.19%0.69%56-3.45%3134.78%
30 Sep, 2310117.44%32,334,28533.13%107.10%1.63%5852.63%23-17.86%
30 Jun, 2386-7.53%24,288,5203.35%80.96%1.32%38-24.00%2855.56%
31 Mar, 23935.68%23,500,248-0.17%78.33%1.24%5047.06%18-47.06%
31 Dec, 228815.79%23,540,4581.84%79.37%1.31%3413.33%3417.24%
30 Sep, 2276-5.00%23,115,3351.85%77.89%1.33%30-37.50%2981.25%
30 Jun, 2280-27.93%22,695,86712.45%76.55%1.65%48-5.88%16-62.79%
31 Mar, 2211112.12%20,182,855-6.33%68.17%1.22%51-23.88%4372.00%
31 Dec, 219939.44%21,547,78351.83%74.84%2.33%6791.43%254.17%
30 Sep, 217133.96%14,192,09314.34%56.68%2.13%356.06%2484.62%
30 Jun, 215335.90%12,412,6398.68%51.61%1.93%3326.92%1385.71%
31 Mar, 213944.44%11,420,90055.84%51.68%4.27%2662.50%740.00%
31 Dec, 202750.00%7,328,447-2.94%34.80%2.30%16128.57%5-28.57%
30 Sep, 201820.00%7,550,16320.08%38.86%3.21%7-7250.00%
30 Jun, 201515.38%6,287,8375.19%34.78%3.15%7-2-33.33%
31 Mar, 201362.50%5,977,3541.28%33.21%1.16%7600.00%3-25.00%
31 Dec, 198-27.27%5,901,993-8.44%53.43%1.57%1-66.67%4-
30 Sep, 1911-21.43%6,446,149-2.85%58.36%0.71%3-78.57%4-
30 Jun, 1914-6,635,216-90.92%-14---

Bicycle Therapeutics Insider Shareholders Trades


Open Market Insider Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Apr 12, 2024Hannay Michael Charles Fergusonofficer CHIEF PROD & SUPPLY CHAIN OFFS-SaleSell257$22.49$5.78K22,891
Apr 05, 2024Lee Kevindirector, officer CHIEF EXECUTIVE OFFICERS-SaleSell3,158$23.81$75.19K387,270
Apr 05, 2024Skynner Michaelofficer CHIEF TECHNOLOGY OFFICERS-SaleSell955$23.81$22.74K94,884
Apr 05, 2024Milnes Alistairofficer CHIEF OPERATING OFFICERS-SaleSell955$23.81$22.74K72,241
Apr 05, 2024Keen Nicholasofficer CHIEF SCIENTIFIC OFFICERS-SaleSell790$23.81$18.81K62,803
Apr 05, 2024Crockett Nigelofficer CHIEF BUSINESS OFFICERS-SaleSell955$23.81$22.74K47,761
Apr 05, 2024Thompson Travis Alvinofficer CHIEF ACCOUNTING OFFICERS-SaleSell152$23.81$3.62K23,223

Open Market Insider Buys

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource

Insider Sells

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Apr 12, 2024Hannay Michael Charles Fergusonofficer CHIEF PROD & SUPPLY CHAIN OFFS-SaleSell257$22.49$5.78K22,891
Apr 05, 2024Lee Kevindirector, officer CHIEF EXECUTIVE OFFICERS-SaleSell3,158$23.81$75.19K387,270
Apr 05, 2024Skynner Michaelofficer CHIEF TECHNOLOGY OFFICERS-SaleSell955$23.81$22.74K94,884
Apr 05, 2024Milnes Alistairofficer CHIEF OPERATING OFFICERS-SaleSell955$23.81$22.74K72,241
Apr 05, 2024Keen Nicholasofficer CHIEF SCIENTIFIC OFFICERS-SaleSell790$23.81$18.81K62,803
Apr 05, 2024Crockett Nigelofficer CHIEF BUSINESS OFFICERS-SaleSell955$23.81$22.74K47,761
Apr 05, 2024Thompson Travis Alvinofficer CHIEF ACCOUNTING OFFICERS-SaleSell152$23.81$3.62K23,223
Mar 21, 2024Hannay Michael Charles Fergusonofficer CHIEF PROD & SUPPLY CHAIN OFFSell---23,148
Mar 21, 2024Hannay Michael Charles Fergusonofficer CHIEF PROD & SUPPLY CHAIN OFFSell16,400$29.60$485.44K-
Mar 21, 2024Hannay Michael Charles Fergusonofficer CHIEF PROD & SUPPLY CHAIN OFFSell50,000$28.81$1.44M-
Mar 21, 2024Hannay Michael Charles Fergusonofficer CHIEF PROD & SUPPLY CHAIN OFFSell31,000$18.08$560.48K-

All Insider Owners Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Apr 22, 2024BAKER BROS. ADVISORS LPdirector, 10 percent owner A-AwardBuy12,000--6,449,320
Apr 22, 2024BAKER BROS. ADVISORS LPdirector, 10 percent owner A-AwardBuy12,000--591,856
Apr 22, 2024BAKER BROS. ADVISORS LPdirector, 10 percent owner A-AwardBuy24,000$21.82$523.68K24,000
Apr 18, 2024BAKER BROS. ADVISORS LPdirector, 10 percent owner Buy---6,437,320
Apr 18, 2024BAKER BROS. ADVISORS LPdirector, 10 percent owner Buy---579,856
Apr 18, 2024BAKER BROS. ADVISORS LPdirector, 10 percent owner Buy4,342,429---
Apr 12, 2024Hannay Michael Charles Fergusonofficer CHIEF PROD & SUPPLY CHAIN OFFS-SaleSell257$22.49$5.78K22,891
Apr 05, 2024Lee Kevindirector, officer CHIEF EXECUTIVE OFFICERS-SaleSell3,158$23.81$75.19K387,270
Apr 05, 2024Skynner Michaelofficer CHIEF TECHNOLOGY OFFICERS-SaleSell955$23.81$22.74K94,884
Apr 05, 2024Milnes Alistairofficer CHIEF OPERATING OFFICERS-SaleSell955$23.81$22.74K72,241
Apr 05, 2024Keen Nicholasofficer CHIEF SCIENTIFIC OFFICERS-SaleSell790$23.81$18.81K62,803
Apr 05, 2024Crockett Nigelofficer CHIEF BUSINESS OFFICERS-SaleSell955$23.81$22.74K47,761
Apr 05, 2024Thompson Travis Alvinofficer CHIEF ACCOUNTING OFFICERS-SaleSell152$23.81$3.62K23,223
Mar 21, 2024Hannay Michael Charles Fergusonofficer CHIEF PROD & SUPPLY CHAIN OFFA-AwardBuy58,000$24.12$1.40M58,000
Mar 21, 2024Hannay Michael Charles Fergusonofficer CHIEF PROD & SUPPLY CHAIN OFFSell---23,148
Mar 21, 2024Hannay Michael Charles Fergusonofficer CHIEF PROD & SUPPLY CHAIN OFFSell16,400$29.60$485.44K-
Mar 21, 2024Hannay Michael Charles Fergusonofficer CHIEF PROD & SUPPLY CHAIN OFFSell50,000$28.81$1.44M-
Mar 21, 2024Hannay Michael Charles Fergusonofficer CHIEF PROD & SUPPLY CHAIN OFFSell31,000$18.08$560.48K-
Feb 21, 2024Sands Stephen H.director-A-AwardBuy24,000$22.50$540.00K24,000
Feb 21, 2024Sands Stephen H.director-A-AwardBuy12,000--12,000

The last insider sell of Bicycle Therapeutics's stock was made by Hannay Michael Charles Ferguson on Apr 12 2024, selling 257 shares at $22.49 per share (valued at $5.78K).

Bicycle Therapeutics Insider Ownership Trends


All Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q2 2024-7-
Q1 20243310330.00%
Q4 2023-6-
Q3 20231616.67%
Q2 2023-13-
Q1 2023277385.71%
Q1 20222721350.00%
Q4 202141428.57%
Q3 2021236535.38%
Q2 2021113135.48%
Q1 2021182378.26%
Q4 20204944.44%
Q3 20201333.33%
Q2 202011100.00%
Q1 202014--
Q4 20191--
Q3 20194--
Q2 20195851113.73%

0 total buy trades, and 7 total sell trades (buy/sell ratio of 0.00%) were made by Bicycle Therapeutics's insiders, as of Q2 2024.

Open Market Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q2 2024-7-
Q1 2024-6-
Q4 2023-6-
Q3 2023-6-
Q2 2023-6-
Q1 2023-7-
Q1 2022---
Q4 2021-10-
Q3 2021-42-
Q2 2021-20-
Q1 2021-18-
Q4 2020-5-
Q3 2020-3-
Q2 2020---
Q1 2020---
Q4 2019---
Q3 2019---
Q2 201911--

As of Q2 2024, Insider owners conducted 0 open market buy trades and 7 open market sell trades of Bicycle Therapeutics's stocks.

Bicycle Therapeutics Peer Ownership


TickerCompany
ANEBAnebulo Pharmaceuticals, Inc.
MLYSMineralys Therapeutics, Inc.
ANABAnaptysBio, Inc.
CCCCC4 Therapeutics, Inc.
MRUSMerus N.V.
KROSKeros Therapeutics, Inc.
ORICORIC Pharmaceuticals, Inc.
IDYAIDEAYA Biosciences, Inc.
INBXInhibrx, Inc.
STOKStoke Therapeutics, Inc.
SEERSeer, Inc.
ACRVAcrivon Therapeutics, Inc. Common Stock
TNYATenaya Therapeutics, Inc.
CGEMCullinan Oncology, Inc.
GLUEMonte Rosa Therapeutics, Inc.
MGTXMeiraGTx Holdings plc
IGMSIGM Biosciences, Inc.
ADAGAdagene Inc.
FIXXQ32 Bio Inc.

BCYC Ownership FAQ


Bicycle Therapeutics is owned by institutional shareholders (12.99%), insiders (0.97%), and public (86.03%). The largest institutional shareholder of Bicycle Therapeutics is BAKER BROS. ADVISORS LP (11.65% of total shares) and the top mutual fund owner is BlackRock Health Sciences Trust II (0.10% of total shares).

Bicycle Therapeutics's major institutional shareholders are BAKER BROS. ADVISORS LP, DEEP TRACK CAPITAL, LP, PARADIGM BIOCAPITAL ADVISORS LP, ARMISTICE CAPITAL, LLC, and TYBOURNE CAPITAL MANAGEMENT (HK) LTD. The top five shareholders own together 35.12% of the company's share outstanding.

As of Mar 2024, there are 48 institutional shareholders of Bicycle Therapeutics.

BAKER BROS. ADVISORS LP owns 4.94M shares of Bicycle Therapeutics, representing 11.65% of the company's total shares outstanding, valued at $123.08M (as of Mar 2024).

As of Mar 2024, DEEP TRACK CAPITAL, LP holds 3.49M shares of Bicycle Therapeutics (BCYC), compromising 8.23% of the company, valued at $86.91M.

PARADIGM BIOCAPITAL ADVISORS LP is the third largest holder of Bicycle Therapeutics. The company owns 3.25M of the company's shares outstanding (worth $80.84M).